This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Futuremed Healthcare Products Corporation To Be Acquired By Cardinal Health Canada For $8.15 Per Share In Cash

TORONTO and DUBLIN, Ohio, Oct. 25, 2011 /PRNewswire/ -- Futuremed Healthcare Products Corporation ("Futuremed") (TSX: FMD) and Cardinal Health Canada Inc. ("Cardinal Health Canada") announced today that they have entered into a support agreement pursuant to which Cardinal Health Canada has agreed to make a cash take-over bid (the "Offer") to acquire all of the outstanding shares of Futuremed for CAD $8.15 per share.  Cardinal Health Canada is a wholly-owned subsidiary of Cardinal Health, Inc. ("Cardinal Health") (NYSE: CAH). The estimated value of the transaction is CAD $165 million.

The Board of Directors of Futuremed (the "Board"), after receiving the recommendation of a Special Committee of Independent Directors, a fairness opinion from CIBC World Markets Inc. and the advice of its other advisors, has unanimously determined that the Offer is in the best interests of Futuremed and recommends that shareholders tender their shares. In addition, certain senior officers and directors of Futuremed, who collectively own shares representing approximately 5% of Futuremed's issued and outstanding shares, have agreed to tender their shares to the Offer.

"This transaction provides an attractive value for our shareholders and positions Futuremed for accelerated growth as part of Cardinal Health, a global leader in the healthcare industry," said John McLaughlin, Chairman of the Board of Futuremed.

Raymond Stone, Futuremed's Chief Executive Officer, noted that "This transaction will enable us to move forward and provide our people with exciting new growth opportunities as part of a larger, more diverse organization, as well as offer our customers more choice with the same outstanding service levels."

"We believe that the acquisition of Futuremed will enhance our capability to serve and deliver greater value to our Canadian patients across the continuum of care. Further, we expect to generate significant synergies as we build off our existing platforms and business partner relationships enabling more efficient offerings to our customers," said David Lees, President and CEO of Cardinal Health Canada.

Offer Overview

Details of the Offer will be made available through a formal take-over bid circular and directors' circular, which are expected to be mailed to all Futuremed shareholders in approximately two weeks. A copy of the take-over bid circular, directors' circular and supporting documents will also be available online following the mailing to shareholders under Futuremed's profile at www.sedar.com or on the Futuremed website at www.futuremed.ca. Futuremed shareholder inquiries regarding the transaction should be directed to Georgeson, Inc. the information agent for the Offer at 866-856-4733.

The Offer is subject to a minimum of 66 2/3% of the outstanding common shares of Futuremed being deposited to the Offer. The transaction is also subject to receipt of certain regulatory approvals and other customary conditions. Terms of the support agreement include the payment of a CAD $4.6 million termination fee to Cardinal Health if the transaction does not proceed in certain circumstances.

Pending satisfaction of the closing conditions, the Offer is expected to close by the first quarter of the 2012 calendar year.  CIBC World Markets Inc. and JMP Securities LLC acted as financial advisors and Goodmans LLP acted as legal counsel to Futuremed on the transaction; Stikeman Elliott LLP acted as legal counsel to Cardinal Health and Cardinal Health Canada on the transaction.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,982.59 +22.02 0.13%
S&P 500 1,978.91 +0.57 0.03%
NASDAQ 4,444.9090 -4.6550 -0.10%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs